Miłosz Regulski Selected Research

Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)

4/2016

COX-2 inhibitors: a novel strategy in the management of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miłosz Regulski Research Topics

Disease

4	Neoplasms (Cancer) 01/2019 - 11/2012
1	Inflammation (Inflammations) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Breast Neoplasms (Breast Cancer) 04/2016
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Dehydration (Water Stress) 11/2013

Drug/Important Bio-Agent (IBA)

2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2019
1	Cardiovascular AgentsIBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Cardiac GlycosidesIBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2016
1	Dosage Forms (Dosage Form)IBA 11/2013
1	DiketopiperazinesIBA 11/2013
1	imidaprilIBA 11/2013

Therapy/Procedure

2	Therapeutics 03/2014 - 11/2012